Aires (Therapeutic Devices)

Xiamen, China · Founded 2020 · Privately Held (backing)

Manufacturer of contact lenses and colored lenses intended for clinical correction and daily cosmetic wear. Aires (Therapeutic Devices) is based in Xiamen, China and was founded in 2020.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—

Aires (Therapeutic Devices) key facts

  • Manufacturer of contact lenses and colored lenses intended for clinical correction and daily cosmetic wear.
  • Notable investors include GL Ventures, Plum Ventures, Source Code Capital, Vision Plus Capital, Xiamen Venture Capital — 9 tracked in total.
  • Status: Privately Held (backing).
Free account
More of Aires (Therapeutic Devices) with a free account
  • ·Watch Aires (Therapeutic Devices): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Aires (Therapeutic Devices) funding rounds

No rounds on record

No funding rounds for Aires (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Aires (Therapeutic Devices) investors

9 investors are on record for Aires (Therapeutic Devices), including GL Ventures, Plum Ventures, Source Code Capital and Vision Plus Capital.

About Aires (Therapeutic Devices)

Manufacturer of contact lenses and colored lenses intended for clinical correction and daily cosmetic wear. The company provides end-to-end eyewear fabrication and Class III medical device production and sales, providing consumers with access to safe and reliable vision-care solutions.

Sector
Healthcare
HQ
Xiamen, China
Founded
2020
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Aires (Therapeutic Devices) doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.